• About
  • Contact
  • Resources
  • Book Nook
Donate
  • Featured
  • Commentary
  • Science & News
  • Mainstream
    • Mainstream Prevention
    • Mainstream Treatment
    • Vaccines
    • Repurposed Drugs
  • Integrative
    • Integrative Prevention
    • Integrative Treatments
    • Integrative Recovery
      • Long Haul
  • Controversies
    • Ivermectin
  • Blog
    • Michael Lerner’s Blog
    • Guest Authors
MenuClose
  • Featured
  • Commentary
  • Science & News
  • Mainstream Solutions
    • Mainstream Prevention
    • Mainstream Treatment
    • Vaccines
    • Repurposed Drugs
  • Integrative Therapies
    • Integrative Prevention
    • Integrative Treatments
    • Integrative Recovery
      • Long Haul
  • Controversies
    • Ivermectin
  • Blog
    • Guest Authors
    • Michael Lerner’s Blog
  • About
  • Contact
  • Resources
  • Donate

Melissa Davey


Covid treatment sotrovimab can cause drug-resistant mutation, study finds

Covid treatment sotrovimab can cause drug-resistant mutation, study finds

by Covid Strategies | Mar 10, 2022 | Featured

Australian researchers raise concerns mutated virus could spread in the community if patients given the drug are not monitored By Melissa Davey  Australian virologists have uncovered a drug-resistant mutation in the Covid-19 virus associated with the drug sotrovimab...

read more
Huge study supporting ivermectin as Covid treatment withdrawn over ethical concerns

Huge study supporting ivermectin as Covid treatment withdrawn over ethical concerns

by Covid Strategies | Jul 15, 2021 | Controversies, Ivermectin, Repurposed Drugs

The preprint endorsing ivermectin as a coronavirus therapy has been widely cited, but independent researchers find glaring discrepancies in the data By Melissa Davey The efficacy of a drug being promoted by rightwing figures worldwide for treating Covid-19 is in...

read more

Address:

Commonweal P.O Box 316 | Bolinas, CA 94924

Latest Covid news in your inbox!

Success!

Subscribe

Search Articles

©2021 CovidStrategies/Commonweal | Site maintained by Mercury Multimedia

Privacy Policy | Home